Linda Hammerich

4.1k total citations · 2 hit papers
51 papers, 2.9k citations indexed

About

Linda Hammerich is a scholar working on Immunology, Oncology and Epidemiology. According to data from OpenAlex, Linda Hammerich has authored 51 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Immunology, 23 papers in Oncology and 14 papers in Epidemiology. Recurrent topics in Linda Hammerich's work include Immunotherapy and Immune Responses (15 papers), Immune Cell Function and Interaction (14 papers) and Cancer Immunotherapy and Biomarkers (12 papers). Linda Hammerich is often cited by papers focused on Immunotherapy and Immune Responses (15 papers), Immune Cell Function and Interaction (14 papers) and Cancer Immunotherapy and Biomarkers (12 papers). Linda Hammerich collaborates with scholars based in Germany, United States and Canada. Linda Hammerich's co-authors include Frank Tacke, Felix Heymann, Joshua Brody, Tom Luedde, Christian Trautwein, Adam Binder, Nikolaus Gaßler, Isabella Lurje, Christian Liedtke and Brian D. Brown and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Nature Medicine.

In The Last Decade

Linda Hammerich

50 papers receiving 2.8k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Hepatic inflammatory responses in liver fibrosis

2023 385 citations Linda Hammerich, Frank Tacke Nature Reviews Gastroenterology & Hepatology profile →
Systemic clinical tumor regressions and potentiation of PD1 blockade with in situ vaccination

2019 321 citations Linda Hammerich, Thomas U. Marron et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Linda Hammerich Germany	24	1.3k	919	778	666	653	51	2.9k
Takuya Miyagi Japan	34	1.8k 1.4×	1.0k 1.1×	825 1.1×	774 1.2×	1.3k 2.0×	104	4.0k
Satoshi Yamagiwa Japan	29	1.5k 1.2×	576 0.6×	654 0.8×	635 1.0×	548 0.8×	106	3.0k
Feng Shi China	21	619 0.5×	404 0.4×	353 0.5×	650 1.0×	750 1.1×	76	2.3k
Shishir Shetty United Kingdom	21	799 0.6×	723 0.8×	769 1.0×	483 0.7×	566 0.9×	81	2.4k
Shosaku Narumi Japan	27	1.5k 1.1×	408 0.4×	335 0.4×	690 1.0×	331 0.5×	45	2.5k
David Scholten Germany	16	444 0.3×	1.4k 1.5×	1.5k 1.9×	270 0.4×	608 0.9×	24	2.8k
Oliver Krenkel Germany	14	879 0.7×	1.3k 1.4×	1.0k 1.3×	296 0.4×	625 1.0×	24	2.7k
Takashi Suda Japan	15	1.6k 1.3×	671 0.7×	395 0.5×	576 0.9×	2.1k 3.2×	30	3.6k
Johannes Herkel Germany	32	1.2k 0.9×	1.6k 1.7×	1.9k 2.4×	391 0.6×	503 0.8×	73	3.5k
Weici Zhang United States	33	778 0.6×	1.0k 1.1×	1.4k 1.7×	392 0.6×	526 0.8×	78	2.7k

Countries citing papers authored by Linda Hammerich

Since Specialization

Citations

This map shows the geographic impact of Linda Hammerich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Linda Hammerich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Linda Hammerich more than expected).

Fields of papers citing papers by Linda Hammerich

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Linda Hammerich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Linda Hammerich. The network helps show where Linda Hammerich may publish in the future.

Co-authorship network of co-authors of Linda Hammerich

This figure shows the co-authorship network connecting the top 25 collaborators of Linda Hammerich. A scholar is included among the top collaborators of Linda Hammerich based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Linda Hammerich. Linda Hammerich is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Riesner, Katarina, Linda Hammerich, Denise Jahn, et al.. (2025). What must not be named. EMBO Reports. 26(8). 1929–1934.

Kraaijeveld, Adriaan O., Adelina Curaj, Kanin Wichapong, et al.. (2024). CCL18 aggravates atherosclerosis by inducing CCR6-dependent T-cell influx and polarization. Frontiers in Immunology. 15. 1327051–1327051. 5 indexed citations

Subramanian, Pallavi, et al.. (2023). Hepatic Stellate Cells: Dictating Outcome in Nonalcoholic Fatty Liver Disease. Cellular and Molecular Gastroenterology and Hepatology. 15(6). 1277–1292. 36 indexed citations

Hammerich, Linda & Frank Tacke. (2023). Hepatic inflammatory responses in liver fibrosis. Nature Reviews Gastroenterology & Hepatology. 20(10). 633–646. 385 indexed citations breakdown →

Engelmann, Cornelius, Abeba Habtesion, Mohsin Hassan, et al.. (2022). Combination of G-CSF and a TLR4 inhibitor reduce inflammation and promote regeneration in a mouse model of ACLF. Journal of Hepatology. 77(5). 1325–1338. 60 indexed citations

Svensson‐Arvelund, Judit, Mark Aleynick, Linda Hammerich, et al.. (2022). Expanding cross-presenting dendritic cells enhances oncolytic virotherapy and is critical for long-term anti-tumor immunity. Nature Communications. 13(1). 7149–7149. 38 indexed citations

Bruneau, Alix, et al.. (2022). Ferroptosis in Cancer Immunotherapy—Implications for Hepatocellular Carcinoma. SHILAP Revista de lepidopterología. 2(1). 185–217. 7 indexed citations

Mohr, Raphael, Burcin Özdirik, Joeri Lambrecht, et al.. (2021). From Liver Cirrhosis to Cancer: The Role of Micro-RNAs in Hepatocarcinogenesis. International Journal of Molecular Sciences. 22(3). 1492–1492. 21 indexed citations

Geisler, Lukas, Raphael Mohr, Joeri Lambrecht, et al.. (2021). The Role of miRNA in the Pathophysiology of Neuroendocrine Tumors. International Journal of Molecular Sciences. 22(16). 8569–8569. 13 indexed citations

10.

Detjen, Katharina, Lukas Geisler, Pamela Riemer, et al.. (2021). Elevated Flt3L Predicts Long-Term Survival in Patients with High-Grade Gastroenteropancreatic Neuroendocrine Neoplasms. Cancers. 13(17). 4463–4463. 6 indexed citations

11.

Mohr, Raphael, Burcin Özdirik, Joeri Lambrecht, et al.. (2021). Lessons From Immune Checkpoint Inhibitor Trials in Hepatocellular Carcinoma. Frontiers in Immunology. 12. 652172–652172. 23 indexed citations

12.

Detjen, Katharina, Linda Hammerich, Burcin Özdirik, et al.. (2020). Models of Gastroenteropancreatic Neuroendocrine Neoplasms: Current Status and Future Directions. Neuroendocrinology. 111(3). 217–236. 16 indexed citations

13.

Marron, Thomas U., Mark Aleynick, Linda Hammerich, et al.. (2019). Antitumor T-cell Homeostatic Activation Is Uncoupled from Homeostatic Inhibition by Checkpoint Blockade. Cancer Discovery. 9(11). 1520–1537. 13 indexed citations

14.

Hammerich, Linda, Maxime Dhainaut, Tibor Keler, et al.. (2017). In Situ Vaccination Improves Efficacy of PD-1 Blockade in Unresponsive Lymphoma Tumors through Induction of a Highly Efficient Cross-Presenting Dendritic Cell Subset Expressing TLR3. Blood. 130. 4106–4106. 1 indexed citations

15.

Hammerich, Linda, Nina Bhardwaj, Holbrook E. Kohrt, & Joshua Brody. (2016). In Situ Vaccination for the Treatment of Cancer. Immunotherapy. 8(3). 315–330. 77 indexed citations

16.

Berger, Katja, Jörg‐Martin Bangen, Linda Hammerich, et al.. (2014). Origin of regenerating tubular cells after acute kidney injury. Proceedings of the National Academy of Sciences. 111(4). 1533–1538. 113 indexed citations

17.

Hammerich, Linda, Olivier Govaere, Henning W. Zimmermann, et al.. (2013). Chemokine Receptor CCR6-Dependent Accumulation of γδ T Cells in Injured Liver Restricts Hepatic Inflammation and Fibrosis. Hepatology. 59(2). 630–642. 153 indexed citations

18.

Hammerich, Linda & Frank Tacke. (2013). Eat more carrots? Dampening cell death in ethanol-induced liver fibrosis by β-carotene.. PubMed. 2(5). 248–51. 4 indexed citations

19.

Heymann, Felix, Linda Hammerich, Matthias Bartneck, et al.. (2011). Hepatic macrophage migration and differentiation critical for liver fibrosis is mediated by the chemokine receptor C-C motif chemokine receptor 8 in mice. Hepatology. 55(3). 898–909. 146 indexed citations

20.

Hammerich, Linda, Felix Heymann, & Frank Tacke. (2010). Role of IL-17 and Th17 Cells in Liver Diseases. SHILAP Revista de lepidopterología. 2011. 1–12. 217 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact